 |
Remicade 8-week dosing effective in maintaining fistula closures in Crohn's patients
Friday, February 27, 2004 15:00 IST
Philadelphia
A study published in the New England Journal of Medicine demonstrates the safety and efficacy of Remicade (infliximab)
Read complete story ...
(You will need to login first to read this story.)
|
|
|
